Open main menu
Home
Random
Donate
Recent changes
Special pages
Community portal
Preferences
About Stockhub
Disclaimers
Search
User menu
Talk
Contributions
Create account
Log in
Editing
Vertex Pharmaceuticals Incorporated
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
=== Yumanity Therapeutics: === Valued at $19.5 million, revenue for FY 2022 $2 million and net income $63.4 million. Yumanity Therapeutics, previously known as Proteostasis Therapeutics, is an active biopharmaceutical company based in Boston, MA, US, founded in 2014. The company focuses on developing therapeutics to address diseases resulting from an imbalance in the proteostasis network. Its specialization includes medicines for cystic fibrosis and treatments for unfolded protein response dysfunction. As a public company, Yumanity Therapeutics is actively engaged in advancing its mission to provide innovative solutions for these challenging medical conditions.
Summary:
Please note that all contributions to Stockhub may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Stockhub:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)